Integrated Wealth Concepts LLC Lineage Cell Therapeutics, Inc. Transaction History

Integrated Wealth Concepts LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.02 - $1.5 $10,200 - $15,000	10,000 New	10,000 $12,000
Q1 2022 May 12, 2022	BUY	$1.21 - $2.48 $12,100 - $24,800	10,000 New	10,000 $15,000
Q2 2021 Aug 13, 2021	SELL	$2.17 - $3.0 $21,700 - $30,000	-10,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.77 - $3.1 $17,700 - $31,000	10,000 New	10,000 $24,000

121

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Wealth Concepts LLC with notifications on news.